Shareholders approve charter amendment and related proposals
Gossamer Bio held a special shareholder meeting on July 14, 2026.
Shareholders authorized potential share issuance tied to conversion of up to $72 million of 7.50% Convertible Senior Secured First Lien Notes due 2030 and exercise of 135,789,000 warrants.
Investors adopted an amended and restated 2019 Incentive Award Plan, increasing the shares reserved for issuance under the plan.
Shareholders authorized a charter amendment raising authorized common shares to 4,000,000,000 from 700,000,000; the amendment was filed and became effective.
Investors also backed alternate charter amendments permitting a reverse stock split with a proportionate cut in authorized shares; no execution was confirmed.
GOSS•
